Cushing Syndrome
Endocrinology·MeSH: Cushing Syndrome
Prevalence
0.5 / 100K
2 drugs in development·2 companies·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| relacorilant | CORCEPT THERAPEUTICS INC (CORT) |
Phase 2(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Cushing Syndrome?
BioSniper tracks 2 drugs in development for Cushing Syndrome across 2 companies.
How many clinical trials target Cushing Syndrome?
There are 3 clinical trials targeting Cushing Syndrome tracked by BioSniper.
What is the prevalence of Cushing Syndrome?
The estimated prevalence of Cushing Syndrome is approximately 0.5 per 100,000 population.
Deep-dive into Cushing Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis